HCWB HCW BIOLOGICS INC Capital Structure Changes 8-K Filing 2025 - Equity Agreement On February 20, 2025, HCW Biologics Inc. entered into an Equity Purchase Agreement with Square Gate Capital Master Fund, agreeing to submit a registration statement to the SEC by April 6, 2025, and on April 4, 2025, submitted a preliminary registration statement for resale of shares. The SEC will not review the registration statement but HCW plans to request acceleration for effectiveness by April 16, 2025.Get access to all SEC 8-K filings of the HCW BIOLOGICS INC